Jan 28 · 3 min read · The pharmaceutical sector is increasingly turning to external collaborators to speed innovation, manage spending, and expand capacity. Central to this evolution are Contract Development and Manufacturing Organizations, whose involvement now spans ear...
Join discussion
Dec 21, 2025 · 3 min read · The pharmaceutical sector has experienced a profound shift over the past decade, largely fueled by the growing involvement of cdmo services providers. These contract development and manufacturing organization partners assist drug developers across ev...
Join discussion
Oct 15, 2025 · 3 min read · The global pharmaceutical industry is rapidly shifting toward outsourcing models that improve efficiency, reduce costs, and accelerate innovation. At the center of this transformation is the CDMO Pharma Company in India, a growing sector that combine...
Join discussionOct 13, 2025 · 6 min read · Discover how the UK Cell and Gene Therapy CDMO Market, valued at USD 80.13 million in 2024, is forecast to skyrocket to USD 287.57 million by 2032, driven by a 16.14% CAGR. Learn about the impact of growing demand for advanced therapeutics, expanding...
Join discussionOct 12, 2025 · 7 min read · The U.S. Cell and Gene Therapy CDMO Market is driving a revolution in personalized medicine, projected to skyrocket from $2.41 billion in 2024 to $9.53 billion by 2032, exhibiting a robust 17.50% CAGR. This explosive growth is fueled by critical fact...
Join discussionOct 10, 2025 · 6 min read · The landscape of modern medicine is undergoing a profound transformation, driven by the emergence of Cell and Gene Therapy (CGT). These advanced therapeutic modalities, which include curative treatments for previously intractable diseases, are redefi...
Join discussionAug 4, 2025 · 3 min read · In today’s fast-evolving life sciences and pharmaceutical landscape, Contract Development and Manufacturing Organizations (CDMOs) play a pivotal role in accelerating drug development and production. As biotech and pharma companies face increasing com...
Join discussion